Bortezomib 2 mg Injection
Marketer |
Glenmark Pharmaceuticals Ltd
|
SALT COMPOSITION |
Bortezomib 2 mg Injection
|
Storage |
Store below 25°C
|
Product details
Product details
What is Bortezomib?
Bortezomib is a potent proteasome inhibitor primarily used in the treatment of multiple myeloma and certain types of lymphoma. By disrupting the proteasome’s function, Bortezomib interferes with the degradation of regulatory proteins, leading to cell cycle arrest and apoptosis (programmed cell death) in malignant cells.
Uses of Bortezomib 2 mg Injection
- Multiple Myeloma: Bortezomib is primarily used for patients with relapsed or refractory multiple myeloma. It can be used alone or in combination with other medications.
- Lymphoma: It is also effective in treating specific types of non-Hodgkin lymphoma, particularly those that are resistant to other treatments.
- Clinical Trials: Bortezomib is under investigation for various other hematological malignancies and solid tumors, showcasing its potential as a versatile therapeutic agent.
Dosage Information
Bortezomib is typically administered as an injection, either subcutaneously or intravenously, with the dosage and schedule varying based on the individual’s condition and response to treatment. Always follow the healthcare provider’s instructions.
Side Effects of Bortezomib
Like any medication, Bortezomib can cause side effects. Common side effects include:
- Nausea and Vomiting: Many patients experience gastrointestinal discomfort.
- Fatigue: Tiredness is a frequent complaint among patients undergoing treatment.
- Peripheral Neuropathy: Nerve damage can lead to tingling or pain, particularly in the hands and feet.
- Low Blood Cell Counts: Bortezomib can cause decreased levels of red and white blood cells, increasing infection risk.
- Diarrhea: Some patients may experience gastrointestinal issues.
- Hypotension: A drop in blood pressure can occur, especially after administration.
Why Choose Ameridrugs?
Ameridrugs is a trusted pharmaceutical exporter worldwide, committed to delivering quality medications, including Bortezomib 2 mg Injection. With a promise of 6 to 8 days of the fastest shipping, Ameridrugs ensures that patients receive their medications promptly and efficiently, minimizing delays in treatment.
Conclusion
Bortezomib 2 mg Injection plays a crucial role in the management of multiple myeloma and certain lymphomas. Understanding its uses, side effects, and proper administration is vital for maximizing its therapeutic benefits. Always consult your healthcare provider for personalized advice and treatment options.
FAQs
FAQs
About the brand
Ameridrugs
Send your Requirments
Send your Requirments
Write your Requird Pharmacy, our Expert will Contect you regarding your Medicine Requirments..